Anne J Gonzales-Luna

15PUBLICATIONS
36CO-AUTHORS
Infectious agentsEpidemiological methodsPharmacogenomicsFood properties (incl. characteristics and health benefits)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 08, 2024
Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Specific Ribotypes.

Taryn A Eubank, Chetna Dureja, Anne J Gonzales-Luna

|Oct 16, 2024
Informing estimates of probability of Clostridioides difficile infection for testing and treatment: expert consensus from a modified-Delphi procedure.

Jonathan D Baghdadi, Mia Wessel, Erik R Dubberke

|Feb 21, 2024
Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Lower Rates of Initial Cure and Sustained Clinical Response.

Taryn A Eubank, Chetna Dureja, Kevin W Garey

|Sep 28, 2023
The Significance of Bayesian Pharmacokinetics in Dosing for Critically Ill Patients: A Primer for Clinicians Using Vancomycin as an Example.

Faris S Alnezary, Masaad Saeed Almutairi, Anne J Gonzales-Luna

|Jun 15, 2023
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies.

Anne J Gonzales-Luna, Travis J Carlson, Kevin W Garey

|Mar 23, 2023
Preservation of the Innate Immune Response to Clostridioides difficile Infection in Hospitalized Immunocompromised Patients.

Marcela Banegas, Javier Villafuerte-Gálvez, Rodrigo Paredes

Pageof 3